Press release - 16/07/2026 New Findings on Acute Leukemias: Specific Mutations Provide Targets for More Targeted Therapies Researchers at the NCT Heidelberg and the German Cancer Research Center (DKFZ) have, for the first time, systematically determined how specific mutations promote acute myeloid leukemias. The results show why IDH1- and IDH2-mutated leukemias develop differently despite similar molecular mechanisms—and open up new approaches for diagnostics and targeted therapies. https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-findings-acute-leukemias-specific-mutations-provide-targets-more-targeted-therapies
Press release - 16/07/2026 Impact of Overweight on Cancer Risk May Be Significantly Underestimated Being overweight and obesity may contribute to significantly more cancer cases than previously thought. This is the conclusion reached by researchers at the German Cancer Research Center (DKFZ). Their analysis shows that when more accurate measures of body fat and methodological biases are considered, more than 10 percent of all cancer cases can be attributed to increased body weight - nearly twice as many as previous estimates suggested.https://www.gesundheitsindustrie-bw.de/en/article/press-release/impact-overweight-cancer-risk-may-be-significantly-underestimated
Press release - 07/07/2026 Polyomaviruses: new approaches to prevention and treatment In people with severely compromised immune systems, the JC polyomavirus can trigger a currently untreatable, usually fatal brain disease. Now, an international research team looking at the viral capsid has identified binding sites for neutralizing antibodies; these sites could be used to halt infection with JC polyomaviruses.https://www.gesundheitsindustrie-bw.de/en/article/press-release/polyomaviruses-new-approaches-prevention-and-treatment
Press release - 02/07/2026 How Tumors Evade Immunotherapy - and How to Prevent It Researchers at the German Cancer Research Center (DKFZ) have identified a previously unknown key mechanism by which cancer cells suppress the immune system and thus evade the effects of immunotherapies. At the same time, the new study in mouse models and human tumor samples points to a promising way to prevent resistance to immunotherapy.https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-tumors-evade-immunotherapy-and-how-prevent-it
Press release - 02/07/2026 Microbial heritage against stress Study points to cross-generational protection provided by an environmental bacterium An environmental bacterium could protect against the effects of stress right through to the next generation. Evidence of this emerged in a study using a mouse model carried out by researchers from Ulm and Frankfurt, the results of which were published in the journal `Molecular Psychiatry´. According to the study, the offspring of treated mothers were better protected against the effects of stress in adulthood than control animals.https://www.gesundheitsindustrie-bw.de/en/article/press-release/microbial-heritage-against-stress-study-points-cross-generational-protection-provided-environmental-bacterium
Press release - 16/06/2026 Kickoff for the EU-Pathfinder Project HEARTCORE at the NMI It goes without saying that new drug compounds should place as little strain on the heart as possible. But how can potential effects be reliably predicted? Researchers from the NMI, Hannover Medical School (project lead), the Universitat Politecnica de Valencia, and industry partners Multi Channel Systems and Foresee Biosystems are tackling this challenge in the new HEARTCORE project.https://www.gesundheitsindustrie-bw.de/en/article/press-release/kickoff-eu-pathfinder-project-heartcore-nmi
Press release - 02/06/2026 New approach to prevent treatment-induced leukemia Protective mechanism against DNA damage caused by chemotherapy and radiotherapy discovered In rare cases, cancer treatments can cause serious long-term effects. These include so-called secondary leukemias. This form of blood cancer can develop when chemotherapy or radiotherapy damages the genetic material of healthy cells. A research team led by a scientist from Ulm has now discovered a molecular protective mechanism against such genomic damage: a peptide.https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-approach-prevent-treatment-induced-leukemia-protective-mechanism-against-dna-damage-caused-chemotherapy-and-radiotherapy-dis
Press release - 26/05/2026 Heidelberg based development revolutionizes hepatitis D therapy worldwide: US Food and Drug Administration (FDA) approves hepatitis drug Hepcludex (bulevirtide) Joint press release of the Heidelberg Faculty of Medicine at Heidelberg University and the German Center for Infection Research: With the FDA approval of Hepcludex (bulevirtide), a therapy for chronic hepatitis D developed at the Heidelberg Faculty of Medicine at Heidelberg University, Heidelberg University Hospital, and the German Center for Infection Research (DZIF) has now reached the world’s most important pharmaceutical market.https://www.gesundheitsindustrie-bw.de/en/article/press-release/heidelberg-based-development-revolutionizes-hepatitis-d-therapy-worldwide-us-food-and-drug-administration-fda-approves-hepatitis
Press release - 15/05/2026 Heidelberg Collaborative Research Centre “Molecular Circuits of Heart Disease” secures second funding period The Collaborative Research Centre (CRC) 1550 “Molecular Circuits of Heart Disease” at Heidelberg University is entering its second funding period. The German Research Foundation (DFG) has approved approximately EUR 17.4 million in funding for the next four years. The spokesperson is Johannes Backs, Professor of Experimental Cardiology at the Heidelberg Faculty of Medicine.https://www.gesundheitsindustrie-bw.de/en/article/press-release/heidelberg-collaborative-research-centre-molecular-circuits-heart-disease-secures-second-funding-period
Press release - 12/05/2026 The Silent Killer: Early Detection and Targeted Treatment of High Blood Pressure High blood pressure is one of the most common causes of heart attacks, strokes, kidney damage, and vascular diseases. Many people affected experience no symptoms for a long time. This is precisely why it is important to check your blood pressure regularly. To mark World Hypertension Day on May 17, the Medical Center – University of Freiburg is providing information on warning signs, diagnosis, and treatment options.https://www.gesundheitsindustrie-bw.de/en/article/press-release/silent-killer-early-detection-and-targeted-treatment-high-blood-pressure
Press release - 11/05/2026 Radar warns of a risk of falling at the hospital The Medical Center – University of Freiburg has implemented a new system that helps nurses identify risky situations early on and provide more targeted assistance / Motion detection is performed using radarhttps://www.gesundheitsindustrie-bw.de/en/article/press-release/radar-warns-risk-falling-hospital
Press release - 11/05/2026 What Really Helps People Quit Smoking Whether people try to quit smoking depends heavily on public health policies in their respective countries – whether they are successful, however, depends primarily on their personal environment and behavior. This was the finding of researchers from the German Cancer Research Center (DKFZ) in an international study.https://www.gesundheitsindustrie-bw.de/en/article/press-release/what-really-helps-people-quit-smoking
Press release - 08/05/2026 The Plasticity of Malignant Brain Tumors as a Potential Therapeutic Approach: Sibylle Assmus Prize for Neuro-Oncology Awarded to Moritz Mall The ability of cancer cells to change their identity makes tumors such as glioblastoma particularly aggressive and resistant to treatment. Moritz Mall, of the German Cancer Research Center (DKFZ) and the Hector Institute for Translational Brain Research (HITBR), is investigating how this plasticity can be specifically restricted. His approach focuses on genetic “guardians” that suppress alternative cell programs. https://www.gesundheitsindustrie-bw.de/en/article/press-release/plasticity-malignant-brain-tumors-potential-therapeutic-approach-sibylle-assmus-prize-neuro-oncology-awarded-moritz-mall
Press release - 07/05/2026 Cooperative project researches interaction of top female athletes’ menstrual cycle, performance and health The Athletin-D project combines the universities of Bochum, Freiburg, Wuppertal and the Technical University of Munich on research into how the performance and health of female athletes could be improved in Olympic and paralympic sports. At the University of Freiburg, the sports psychologist Professor Jana Strahler is studying the interaction of hormonal processes, stress, lifestyle factors and mental health.https://www.gesundheitsindustrie-bw.de/en/article/press-release/cooperative-project-researches-interaction-top-female-athletes-menstrual-cycle-performance-and-health
Press release - 07/05/2026 MRI is a better indicator than BMI of when body fat becomes dangerous MRI analysis of fat and muscle distribution in more than 66,000 people provides a more accurate assessment of health risks / Poor muscle quality poses an additional risk / Study provides reference values based on age, sex, and heighthttps://www.gesundheitsindustrie-bw.de/en/article/press-release/mri-better-indicator-bmi-when-body-fat-becomes-dangerous
Press release - 04/05/2026 Recommendation for Better Protection: Outdoor Workers Particularly Vulnerable to Melanoma, Study Finds As the sun rises higher in the sky this spring, UV exposure increases. This should be addressed with proper sun protection. New data shows that people who work outdoors frequently are at a significantly higher risk of developing melanoma on their faces. At the same time, many affected individuals lack awareness of the risks and fail to use systematic sun protection. https://www.gesundheitsindustrie-bw.de/en/article/press-release/recommendation-better-protection-outdoor-workers-particularly-vulnerable-melanoma-study-finds
Press release - 04/05/2026 How personalised is healthcare? This year’s Health Congress at Furtwangen University (HFU) focused on the timely topic of personalised healthcare. With the theme “Health for EVERYONE! – Successful Strategies Through personalised Healthcare,” HFU hosted the event for the 15th time in collaboration with the Black Forest-Baar Health Network, the Furtwangen University Support Association PRO HFU e.V., and the City of Furtwangen.https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-personalised-healthcare
Digital bone twin by OSORA medical - 04/05/2026 Fractures in focus: predicting rather than waiting Bone fractures are generally healed by the body without any issues. However, there are hundreds of thousands of cases each year in which a fracture either fails to heal or only does so slowly. To reduce the number of cases where this happens, a start-up called OSORA medical has developed methods to predict the healing process and, if necessary, make preventative adjustments.https://www.gesundheitsindustrie-bw.de/en/article/news/fractures-focus-predicting-rather-waiting
Press release - 24/04/2026 New Medical Director of the Department of Nephrology Prof. Dr. Halbritter has served as the new Medical Director of the Department of Nephrology at the Medical Center – University of Freiburg since April 2026. With his expertise, he is enhancing care for patients with kidney disease: The goal is to prevent kidney failure through early diagnosis and the implementation of strategies to slow disease progression. For cases where kidney failure has already occurred, the focus is on organ replacement.https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-medical-director-department-nephrology
Press release - 15/04/2026 Pacemakers for the Brain Brain-computer interfaces can read neural signals and influence brain activity. We spoke with Pascal Fries about how this technology can benefit people with neurological and psychiatric conditions, future developments, and his views on ethical boundaries.https://www.gesundheitsindustrie-bw.de/en/article/press-release/pacemakers-brain
Press release - 10/04/2026 New study identifies clinically relevant changes in airway wall thickness in COPD and at-risk individuals A recent study published in the European Respiratory Journal provides important new insights into the early identification and monitoring of chronic obstructive pulmonary disease (COPD). The focus is on airway wall thickness as an imaging marker for structural remodeling processes in the lungs.https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-study-identifies-clinically-relevant-changes-airway-wall-thickness-copd-and-risk-individuals
Press release - 09/04/2026 When oxygen determines if a limb can regrow Can Aztekin and his team have discovered how oxygen-sensing explains why amphibians regenerate limbs and mammals do not.https://www.gesundheitsindustrie-bw.de/en/article/press-release/when-oxygen-determines-if-limb-can-regrow
Press release - 07/04/2026 No soft drink before the massage How does sugar affect relaxation exercises? A new study carried out by researchers from the University of Konstanz provides revealing insights into the connection between blood glucose and the autonomic nervous system: The intake of sugar counteracts relaxation.https://www.gesundheitsindustrie-bw.de/en/article/press-release/no-soft-drink-massage
Press release - 01/04/2026 Digital Assistance System Designed to Prevent Recurrent Heart Disease Women who have experienced a stroke or heart attack are at a higher risk of mortality than men. Fraunhofer researchers want to improve gender-specific aftercare with a customized assistance system – thus helping to prevent further heart disease.https://www.gesundheitsindustrie-bw.de/en/article/press-release/digital-assistance-system-designed-prevent-recurrent-heart-disease
Press release - 23/03/2026 Aggravated neuroimmune response, delayed wound healing Transcription factor NF-κB in astrocytes critically affects the outcome of traumatic brain injury (TBI) Traumatic brain injuries often lead to complications with long-lasting consequences on memory, concentration and movement control. Detrimental secondary inflammatory reactions at the injured tissue sites are often responsible for this. Researchers from Ulm have now shown that a transcription factor plays a key role in reactions to TBI. When this gene regulator is activated, an elevated neuroimmune response promotes inflammation.https://www.gesundheitsindustrie-bw.de/en/article/press-release/aggravated-neuroimmune-response-delayed-wound-healing-transcription-factor-nf-kb-astrocytes-critically-affects-outcome-traumatic